glycolaldehyde has been researched along with Fatty Liver in 2 studies
Fatty Liver: Lipid infiltration of the hepatic parenchymal cells resulting in a yellow-colored liver. The abnormal lipid accumulation is usually in the form of TRIGLYCERIDES, either as a single large droplet or multiple small droplets. Fatty liver is caused by an imbalance in the metabolism of FATTY ACIDS.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Yang, K | 1 |
| Feng, C | 1 |
| Lip, H | 1 |
| Bruce, WR | 1 |
| O'Brien, PJ | 1 |
| Lorenzi, R | 1 |
| Andrades, ME | 1 |
| Bortolin, RC | 1 |
| Nagai, R | 1 |
| Dal-Pizzol, F | 1 |
| Moreira, JC | 1 |
2 other studies available for glycolaldehyde and Fatty Liver
| Article | Year |
|---|---|
Cytotoxic molecular mechanisms and cytoprotection by enzymic metabolism or autoxidation for glyceraldehyde, hydroxypyruvate and glycolaldehyde.
Topics: Acetaldehyde; Animals; Copper; Fatty Liver; Glutathione; Glyceraldehyde; Glyoxal; Hepatocytes; Hydro | 2011 |
Oxidative damage in the liver of rats treated with glycolaldehyde.
Topics: Acetaldehyde; Animals; Catalase; Fatty Liver; Glycation End Products, Advanced; Injections, Intraven | 2011 |